SUNOSI

This brand name is authorized in Austria, Estonia, Finland, France, Croatia, Ireland, Israel, Italy, Lithuania, Poland, United Kingdom, United States

Active ingredients

The drug SUNOSI contains one active pharmaceutical ingredient (API):

1 Solriamfetol UNII K7RO88SP7A - SOLRIAMFETOL HYDROCHLORIDE

Solriamfetol is indicated to improve wakefulness in patients with excessive daytime sleepiness associated with narcolepsy or obstructive sleep apnea. Its mechanism of action has not been fully characterised. However, its efficacy could be mediated through its activity as a dopamine and norepinephrine (noradrenaline) reuptake inhibitor (DNRI). Read about Solriamfetol

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
SUNOSI Film‑coated tablet	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N06BA14		N Nervous system → N06 Psychoanaleptics → N06B Psychostimulants, agents used for ADHD and nootropics → N06BA Centrally acting sympathomimetics
Discover more medicines within N06BA14

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EE	Ravimiamet	Identifier(s): 1810101, 1810112, 1810123, 1810134, 1810145, 1810156, 1810167, 1810178, 1810189, 1810190
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 155888, 380455
Country: FR	Base de données publique des médicaments	Identifier(s): 64617815, 67314111
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 389254, 389257
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 9302, 9303
Country: IT	Agenzia del Farmaco	Identifier(s): 048446013, 048446025, 048446037, 048446049, 048446052, 048446064, 048446076, 048446088, 048446090, 048446102
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1089305, 1089306, 1089307, 1089308, 1089309, 1089310, 1089311, 1089312, 1089313, 1089314
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100434474, 100434480
Country: US	FDA, National Drug Code	Identifier(s): 68727-350, 68727-351